How is RoosterBio Pioneering Regenerative Medicine?

Since 2013, RoosterBio has been fueling the rapid implementation of scalable advanced therapies by providing a solution to the industry bottleneck, accelerating hMSC product and process development.

Webinar Recordings

EV Analytics: Know Your Process & Define Your Product

Size, heterogeneity, complex composition, and varying manufacturing processes make exosomes or extracellular vesicles a challenge for conventional analytical tools and strategies.

The Role hMSCs Play in Bioengineering Solutions for Military Medicine

This client-led seminar explores developing enhanced hMSCs as living bioreactors for drug delivery, a biomanufacturing platform for complex biomolecules, 3D-printed orthopedic repair devices, and extracellular vesicles for bioactive bandages.

Rapid Translation of a Cellular Therapeutic

In this webinar, we explore traditional challenges associated with the incorporation of human mesenchymal stem cells into cell therapies and the advances being made to improve clinical manufacturing readiness.

RoosterGEM™: Addressing Key Challenges in Efficient Gene Transfer to Primary Cells

RoosterGEM is the industry's first genetic engineering medium, and in this webinar, you will learn how it can improve transduction efficiency and reduce MOI, leading to lower vector and media costs.

Best Practices in RegenMed Product & Process Development

The goal of this webinar is to discuss the importance of building a strong cost model with a step-by-step MSC-based example and how your model can positively impact your product and process development. 

Planning a Successful MSC Therapy for Rapid COVID Response

This webinar will cover challenges and options available for cell therapy product developers in scaling production, including industry best practices that will deliver rapid, safe, and cost-effective solutions to meet the crisis demand.

Radically Simplifying Production of hMSC-EVs with Rapid Clinical Translation & Scale-up Potential

This presentation highlights strategies and systems that radically simplify the production of large quantities of EVs, as well as cGMP raw material requirements for rapid clinical translation.

Scalable Manufacturing of MSC-derived EVs

In this webinar, we discuss the manufacturing of EVs derived from mesenchymal stem cells, including the tissue source, cell state, and process parameters, and the importance of evaluating productivity in manufacturing processes.

Scaling Up MSC & EV Production in Bioreactors

The focus of this talk is the scale-up of MSC and EV production in bioreactors, including processes for successful commercialization of cell therapy products and quality EV production with the end goal in mind.

Video Library

Subscribe to our channel to stay up-to-date on our complete library of FAQs, interviews, presentations, and more. Improve your knowledge of hMSCs and other Regenerative Medicine topics, as we strive to bring our expertise to the forefront of industry discourse, education, and pioneering.

KOL Interview: Dr. Steven Jay
KOL Interview: Dr. Christian van den Bos
KOL Interview: Dr. Ashok Shetty
KOL Interview: Dr. Ibrahim Ozbolat
FAQs: Media